Root Financial Partners
DMAC icon

Root Financial Partners’s DiaMedica Therapeutics DMAC Stock Holding History

Root Financial Partners’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$132 Buy
+16
New +$112 ﹤0.01% 3600

Other funds holding DMAC

Members Wealth
Members Wealth Media, Pennsylvania $200M AUM 9.84% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GK Wealth Management
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Root Financial Partners's DMAC Position: Q3 2026 in Review

Root Financial Partners opened a new position in DiaMedica Therapeutics (DMAC) in Q3 2026: 16 shares worth $132. The stake represents ﹤0.01% of the portfolio and ranks #3600 among its holdings.

8 funds tracked by Wall St. Rank hold DMAC as of Q3 2026.

  • Root Financial Partners held 16 shares of DiaMedica Therapeutics worth $132 as of Q3 2026.
  • DiaMedica Therapeutics was a new Root Financial Partners position in Q3 2026.
  • DiaMedica Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3600 holding.
  • 8 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.